mariPOC®

母亲是żniejsze informacje

Coronavirus disease 2019 (COVID-19)

In 2019, SARS-CoV-2 emerged as a novel pathogen causing coronavirus disease 2019 (COVID-19). Categorized as a pandemic by the World Health Organisation (WHO) in March 2020, COVID-19 has affected multiple countries across all populated continents. Rapid testing plays an important role as societies seek to contain, delay and mitigate the effects of the outbreak.

With the high degree of contagion of COVID-19 the rapid detection of infected individuals is key to limit the spread further. This needs to be possible nearly everywhere where people come together and, therefore, poses new challenges and needs to point-of-care (POC) testing.

mariPOC® - a fully automated continuous-feed immunoassay analyzer

Part No. H-AD7-020 | mariPOC^®AD7-020 analyzer
System for use with mariPOC^®tests

The mariPOC^®System is a compact solution for high-throughput, rapid Point-Of-Care (POC) testing needs that analyses swab samples fully automatically. With a workflow of less than 3 minutes hands-on time and no need for additional instrumentation, it is an easy-to-use tool to test for pathogens anywhere by suitably trained individuals and in accordance with local regulations. It utilizes modern two-photon excitation fluorometry in combination with immunoassay-based testing to achieve a specificity and sensitivity so far only achieved by state-of-the-art immunoassay laboratories.

Cechy charakterystyczne

Access to SARS-CoV-2 testing everywhere

The mariPOC^®SARS-CoV-2 test supports detection of acute and contagious COVID-19 disease at the site of sampling. An indicative positive result from nasopharyngeal samples can be obtained after 20 minutes for highly positive infections, a final confirmative positive or negative result can be read after 90 minutes. Minimal work steps, automated analysis and the easy-to-use interface allow use even with a large number of patients (up to 300 samples per 24 hours).

mariPOC^®SARS-CoV-2

Product Code	Product Name	Capacity
1204S	mariPOC^®SARS-CoV-2	308 samples/24 h

Prepared for POC testing in winter

The mariPOC^®Respi+ test allows point-of care testing for a broad panel of respiratory-related pathogens covering SARS-CoV-2, Influenza, RSV, Adenovirus, Metapneumovirus, Parainfluenza, Coronavirus OC43 and Streptococcus pneumoniae. From just one sample you get automated analysis for all these pathogens from nasopharyngeal swabs. The indicative positive result is available after 20 minutes for highly positive infections and a final confirmative result to identify if any of the pathogens is positive can be read after 2 hours.